Victor Garcia

Has grant

Assistant Professor

New York Medical College

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Victor Garcia is an Assistant Professor at New York Medical College in the United States. His research focuses on metabolic dysfunction-associated liver diseases, exploring the roles of CYP450 enzymes and genetic variants in health outcomes. Recent articles authored by him delve into adipocyte hypertrophy, vascular biology, and the impact of dietary factors on chronic diseases.

Recent Grants

Grant: Close

NIH T32 Grant

Open Date: 2015-09-01

Close Date: 2018-09-01

Grant: Close

HORMONAL REGULATION OF BLOOD PRESSURE

Open Date: 1985-09-30

Close Date: 2017-03-31

Articles (12)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (2)

Michal Laniado Schwartzman

UNITED STATES

View details

Joseph Miano

Professor

Augusta University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Victor Garcia

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (12)

The CYP4/20-HETE/GPR75 axis in the progression metabolic dysfunction-associated steatosis liver disease (MASLD) to chronic liver disease.

G6pd N126D Variant Increases the Risk of Developing VEGFR (Vascular Endothelial Growth Factor Receptor) Blocker‐Induced Pulmonary Vascular Disease

Loss-of-function G6PD variant moderated high-fat diet-induced obesity, adipocyte hypertrophy, and fatty liver in male rats

The fatty acid omega hydroxylase genes (CYP4 family) in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD): An RNA sequence database analysis and review.

The Synergistic and Opposing Roles of ω-Fatty Acid Hydroxylase (CYP4A11) and ω-1 Fatty Acid Hydroxylase (CYP2E1) in Chronic Liver Disease

Gpr75-deficient mice are protected from high-fat diet-induced obesity.

The importance of “Fit”: an interview with Victor Garcia on vascular biology and enjoying the scientific journey

Blockade of 20-hydroxyeicosatetraenoic acid receptor lowers blood pressure and alters vascular function in mice with smooth muscle-specific overexpression of CYP4A12-20-HETE synthase.

Cytochrome P450 3A4 suppression by epimedium and active compound kaempferol leads to synergistic anti-inflammatory effect with corticosteroid.

Heme-oxygenase and lipid mediators in obesity and associated cardiometabolic diseases: Therapeutic implications.

Uncovering the signalling, structure and function of the 20‐HETE‐GPR75 pairing: Identifying the chemokine CCL5 as a negative regulator of GPR75

Sequencing of 640,000 exomes identifies GPR75 variants associated with protection from obesity

Collaborators (2)

Michal Laniado Schwartzman

Joseph Miano

Make your next move.